The Long COVID Treatment Trial

Korábbi kezelés

• Medication contraindications to tirzepatide
• Planning to undergo elective surgery or procedures requiring general anesthesia or deep sedation in the next 12 months

Más betegség

• Personal or family history of medullary thyroid carcinoma
• History of severe gastrointestinal disease
• Worsening or chronic renal failure
• History of pancreatitis
• Multiple Endocrine Neoplasia syndrome type 2
• Known serious hypersensitivity to tirzepatide
• History of suicidal attempts and/or active suicidal ideation
• Symptoms of fatigue and/or brain fog that predated infection with COVID-19

Egyéb

• Certain vulnerable populations (prisoners, children, fetuses, and institutionalized individuals)
• Women who are pregnant, excluded due to unknown risks to a fetus
• Diagnosis of gastroparesis
• Already taking tirzepatide or another GLP-1 agonist
• Underweight (BMI under 18.5)

• 18 years of age or older Living in the United States Able to read and understand English or Spanish Willing and able to participate in study interventions and activities, including;
• Access to an internet connected device
• Informed Consent
• Surveys
• Medication schedule
• Adverse Event reporting
• Weight reporting
• Use of wearable activity tracker
• Completing at home blood collections, if selected Meets the NASEM definition of Long COVID: an infection-associated chronic condition that occurs after SARS-CoV-2 infection and is present for at least 3 months as a continuous, relapsing and remitting, or progressive disease state that affects one or more organ systems 16.
  • Ability to verify identity Ability to verify diagnosis Agree to notify the study team if you start any other Long COVID treatments while enrolled in the study.
  • Complete the Fatigue Severity Scale with a minimum score of 36